携手“圣博玛”瑞典子公司,加速“重组胶原蛋白”医美国际化步伐

动脉网
Dec 22, 2025

2025年12月21日,巨子生物与Nordberg Medical(长春圣博玛在瑞典卡罗琳斯卡的全资子公司)在上海签署战略合作协议,双方将基于巨子生物的合成生物学技术平台,共同推进重组胶原蛋白在医美与生物医学领域的全球开发与商业化。巨子生物授予Nordberg Medical其专利重组胶原蛋白在除中国内地以外全球市场的开发、生产及商业化权利,用于开发多款医美组织再生产品。巨子生物是全球最早量产重组...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10